Therapeutic targeting of the receptor tyrosine kinase Met

M Sattler, PC Ma, R Salgia - Molecular Targeting and Signal Transduction - Springer
Conclusion There are different options to inhibit Met activation and these are in part limited
depending on the transforming phenotype. For example, inhibiting ligand/receptor …
被引用次数：28 相关文章

Therapeutic Targeting of the Receptor Tyrosine Kinase Met

M Sattler, PC Ma, R Salgia - Molecular Targeting and Signal Transduction - infona.pl
Conclusion There are different options to inhibit Met activation and these are in part limited
depending on the transforming phenotype. For example, inhibiting ligand/receptor …

THERAPEUTIC TARGETING OF THE RECEPTOR TYROSINE KINASE MET

M SATTLER, PC MA, R SALGIA - MOLECULAR TARGETING AND SIGNAL … - Springer
The Met receptor tyrosine kinase was originally identified as the cellular homologue of the
Tpr-Met oncoprotein [1-3]. The Tpr-Met translocation was created by treatment of the human …

THERAPEUTIC TARGETING OF THE RECEPTOR TYROSINE KINASE MET

M SATTLER, PC MA, R SALGIA - Molecular Targeting and …, 2004 - books.google.com
The Met receptor tyrosine kinase was originally identified as the cellular homologue of the
Tpr-Met oncoprotein [1-3]. The Tpr-Met translocation was created by treatment of the human …

[引用][C] Therapeutic targeting of the receptor tyrosine kinase Met

M Sattler, PC Ma, R Salgia - Cancer treatment and …, 2004 - pubmed.ncbi.nlm.nih.gov
Therapeutic targeting of the receptor tyrosine kinase Met Therapeutic targeting of the receptor
tyrosine kinase Met Cancer Treat Res. 2004:119:121-38. doi: 10.1007/1-4020-7847-1_7 …

[引用][C] Therapeutic targeting of the receptor tyrosine kinase Met.

M Sattler, PC Ma, R Salgia - Cancer treatment and research, 2004 - pure.psu.edu
Therapeutic targeting of the receptor tyrosine kinase Met. — Penn State Skip to main navigation
Skip to search Skip to main content Penn State Home Penn State Logo Help & FAQ Home …

[引用][C] Therapeutic targeting of the receptor tyrosine kinase Met.

M Sattler, PC Ma, R Salgia - Cancer Treatment and Research, 2004 - europepmc.org
Therapeutic targeting of the receptor tyrosine kinase Met. - Abstract - Europe PMC Sign in |
Create an account https://orcid.org Europe PMC Menu About Tools Developers Help …

Therapeutic Targeting of the Receptor Tyrosine Kinase Met

M Sattler, PC Ma, R Salgia - Molecular Targeting and Signal Transduction - infona.pl
Conclusion There are different options to inhibit Met activation and these are in part limited
depending on the transforming phenotype. For example, inhibiting ligand/receptor …

[引用][C] Therapeutic Targeting of the Receptor Tyrosine Kinase Met

M Sattler, P Ma, R Salgia - Molecular Targeting and Signal Transduction, 2004 - Springer